Literature DB >> 18789885

Cytotoxicity of lipid-free apolipoprotein B.

Shin-ya Morita1, Yuko Deharu, Eriko Takata, Minoru Nakano, Tetsurou Handa.   

Abstract

To investigate the effect of apolipoprotein B (apoB) on cell viability, we used lipid-free apoB as a model for denatured apoB. Lipid-free apoB had cytotoxicity to J774 macrophages, CHO cells and HepG2 cells, whereas apoB bound to low density lipoprotein (LDL) and lipid-free apolipoprotein A-I had no effect on cell viability. Lipid-free apoB induced apoptosis in J774 macrophages assessed by caspase-3 activation and annexin V binding. LDL receptor, heparan sulfate proteoglycans, and class A scavenger receptor were involved in the binding/uptake of lipid-free apoB, but lipid-free apoB binding/uptake by the cells did not correlate with cytotoxicity. Lipid-free apoB disrupted the lipid bilayer of large unilamellar vesicles containing calcein. We evaluated the interaction between apoB and cellular membrane by monitoring the change in intracellular Ca(2+) concentration using Fura-2, and found that lipid-free apoB rapidly disrupted the cellular membrane in the absence or presence of the inhibitors for cellular binding/uptake mediated by the receptors. Therefore, it is suggested that lipid-free apoB induces cell death by disturbance of the plasma membrane. In addition to other lipid component in modified LDL, apoB itself has an ability to induce apoptosis and plays a crucial role in the development of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789885     DOI: 10.1016/j.bbamem.2008.08.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Change in Brain Plasmalogen Composition by Exposure to Prenatal Undernutrition Leads to Behavioral Impairment of Rats.

Authors:  Kodai Hino; Shunya Kaneko; Toshiya Harasawa; Tomoko Kimura; Shiro Takei; Masakazu Shinohara; Fumiyoshi Yamazaki; Shin-Ya Morita; Shumpei Sato; Yoshihito Kubo; Tadaaki Kono; Mitsutoshi Setou; Mina Yoshioka; Junya Fujino; Hiroyuki Sugihara; Hideto Kojima; Naoto Yamada; Jun Udagawa
Journal:  J Neurosci       Date:  2019-08-07       Impact factor: 6.167

2.  Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells.

Authors:  Shin-ya Morita; Atsushi Sakurai; Minoru Nakano; Shuji Kitagawa; Tetsurou Handa
Journal:  Lipids       Date:  2010-11-16       Impact factor: 1.880

3.  Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics.

Authors:  Jeroen van Bergenhenegouwen; Aletta D Kraneveld; Lieke Rutten; Johan Garssen; Arjan P Vos; Anita Hartog
Journal:  BMC Immunol       Date:  2016-10-28       Impact factor: 3.615

4.  Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts.

Authors:  Yoshito Ikeda; Shin-Ya Morita; Tomohiro Terada
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

5.  Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis.

Authors:  Jamie K Wong; Anna K Roselle; Taylor M Shue; Serena J E Shimshak; Joseph M Beaty; Nadia M Celestin; Ivy Gao; Rose P Griffin; Merit E Cudkowicz; Saud A Sadiq
Journal:  Brain Commun       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.